- Home
- EDIT vs LAKE Comparison
EDIT vs LAKE Comparison
Compare EDIT & LAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- LAKE
- Stock Information
- Founded
- EDIT 2013
- LAKE 1982
- Country
- EDIT United States
- LAKE United States
- Employees
- EDIT N/A
- LAKE N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- LAKE Industrial Specialties
- Sector
- EDIT Health Care
- LAKE Health Care
- Exchange
- EDIT Nasdaq
- LAKE Nasdaq
- Market Cap
- EDIT 176.7M
- LAKE 144.9M
- IPO Year
- EDIT 2016
- LAKE 1986
- Fundamental
- Price
- EDIT $1.32
- LAKE $22.88
- Analyst Decision
- EDIT Buy
- LAKE Strong Buy
- Analyst Count
- EDIT 14
- LAKE 2
- Target Price
- EDIT $8.08
- LAKE $27.50
- AVG Volume (30 Days)
- EDIT 3.3M
- LAKE 50.9K
- Earning Date
- EDIT 11-04-2024
- LAKE 12-05-2024
- Dividend Yield
- EDIT N/A
- LAKE 0.52%
- EPS Growth
- EDIT N/A
- LAKE N/A
- EPS
- EDIT N/A
- LAKE N/A
- Revenue
- EDIT $61,759,000.00
- LAKE $151,822,000.00
- Revenue This Year
- EDIT N/A
- LAKE $34.57
- Revenue Next Year
- EDIT N/A
- LAKE $13.25
- P/E Ratio
- EDIT N/A
- LAKE N/A
- Revenue Growth
- EDIT 150.95
- LAKE 23.99
- 52 Week Low
- EDIT $1.28
- LAKE $15.10
- 52 Week High
- EDIT $11.58
- LAKE $26.10
- Technical
- Relative Strength Index (RSI)
- EDIT 24.88
- LAKE 55.65
- Support Level
- EDIT $1.28
- LAKE $22.62
- Resistance Level
- EDIT $2.37
- LAKE $25.32
- Average True Range (ATR)
- EDIT 0.18
- LAKE 1.32
- MACD
- EDIT -0.04
- LAKE -0.04
- Stochastic Oscillator
- EDIT 6.45
- LAKE 53.26
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.